Expert Dose Conversion Guidance For UK Patients
Complete Mounjaro To Wegovy Dose Conversion Chart For UK Patients
Understanding the Mounjaro to Wegovy dose conversion chart requires recognising these medicines work through different mechanisms. Mounjaro (tirzepatide) is a dual GIP and GLP-1 receptor agonist, whilst Wegovy (semaglutide) targets GLP-1 receptors exclusively. This fundamental difference means direct dose conversions aren't straightforward equivalencies. Your prescriber will typically recommend starting Wegovy's standard escalation schedule rather than attempting direct conversions. EverydayMeds provides expert clinical oversight for patients transitioning between these prescription-only medicines.
The Mounjaro to Wegovy dose conversion chart consideration involves timing your transition carefully to minimise side effects. Most prescribers recommend a washout period between stopping Mounjaro and starting Wegovy, typically 1-2 weeks depending on your previous dose. Wegovy always begins with the 0.25mg starter dose regardless of your previous Mounjaro strength. Our clinical team reviews each transition individually, ensuring your Mounjaro to Wegovy dose conversion follows MHRA-approved protocols. This personalised approach maximises safety whilst maintaining your weight management progress.
UK Wegovy Pricing With Dose Conversion Chart Support
EverydayMeds offers transparent Wegovy pricing with comprehensive Mounjaro to Wegovy dose conversion chart guidance included in every consultation. Single pens start from £79.99 for the 0.25mg starter dose, progressing to £94.99 (0.5mg), £99.99 (1mg), £139.99 (1.7mg), and £209.99 for the 2.4mg maintenance dose. Our Intro Trio bundle (0.25mg, 0.5mg, 1mg) costs £299.99, providing your first three months of treatment with conversion support. New customers apply code FIRST40 at checkout, whilst returning patients use DOSE25 for additional savings.
Bundle options simplify your Mounjaro to Wegovy dose conversion journey by ensuring continuous supply during transition. The Intro Duo (0.25mg and 0.5mg) costs £169.99, covering your initial eight weeks with prescriber monitoring. For patients requiring extended starter phases, our Gentle Start Trio provides two 0.25mg pens plus one 0.5mg pen for £269.99. Every purchase includes detailed conversion guidance, cold-chain delivery, and ongoing clinical support throughout your transition period.
Clinical Evidence Behind Mounjaro To Wegovy Dose Conversion Protocols
Research supporting Mounjaro to Wegovy dose conversion practices stems from individual trial data rather than head-to-head studies. The STEP trials demonstrated Wegovy's efficacy with patients achieving approximately 15% average weight loss at 68 weeks alongside diet and exercise (Wilding et al., NEJM, 2021). These results provide confidence for patients transitioning from other weight management treatments. Clinical protocols recommend standard Wegovy dose escalation regardless of previous treatment experience.
The Mounjaro to Wegovy dose conversion chart consideration includes cardiovascular benefits demonstrated in the SELECT trial, showing 20% reduction in major cardiovascular events. This additional protection may influence prescriber recommendations for patients with existing cardiovascular risk factors. Your clinical assessment will evaluate both previous treatment response and future cardiovascular benefits when planning your conversion strategy.
How Wegovy Works After Mounjaro To Wegovy Dose Conversion
Wegovy functions as a GLP-1 receptor agonist, mimicking your body's natural fullness hormones to reduce appetite and promote satiety after smaller meals. Following your Mounjaro to Wegovy dose conversion, you'll notice Wegovy works primarily through GLP-1 pathways compared to Mounjaro's dual mechanism. This focused approach may provide different appetite control patterns, with many patients reporting sustained fullness between meals. The once-weekly injection schedule remains consistent, maintaining your established routine. Wegovy may also reduce food cravings by working on brain appetite centres, supporting long-term weight management goals alongside reduced-calorie diet and increased physical activity.
Streamlined UK Ordering Process With Conversion Support
Ordering Wegovy with Mounjaro to Wegovy dose conversion chart guidance takes just three minutes through our online clinical assessment. You'll complete questions about your previous Mounjaro treatment, current health status, and weight management goals. Our prescribers review applications within three working days (24 hours express available), providing personalised conversion recommendations based on your individual circumstances. Once approved, genuine Novo Nordisk Wegovy dispatches via next-day cold-chain delivery, maintaining proper temperature control throughout transit. Your package includes detailed injection instructions, dose escalation guidance, and direct access to ongoing clinical support throughout your transition period.
Storage Advantages In Your Mounjaro To Wegovy Dose Conversion
Wegovy offers superior storage flexibility compared to Mounjaro, particularly beneficial during your dose conversion transition period. Whilst Mounjaro requires refrigeration with only 21 days room temperature stability, Wegovy maintains potency for six weeks at room temperature below 30°C once removed from the fridge. This extended stability simplifies travel and reduces storage anxiety during your conversion period. The FlexTouch pen design provides consistent, accurate dosing throughout your escalation schedule from 0.25mg to 2.4mg maintenance. Proper storage ensures optimal medication effectiveness as you progress through your Mounjaro to Wegovy dose conversion journey alongside dietary modifications and exercise increases.
Why UK Patients Choose EverydayMeds For Dose Conversion Charts
EverydayMeds specialises in complex weight management transitions, providing detailed Mounjaro to Wegovy dose conversion charts tailored to UK prescribing practices. Our clinical team understands the nuances of switching between different GLP-1 treatments, offering personalised guidance beyond standard conversion protocols. We maintain comprehensive patient records, tracking your previous Mounjaro response to optimise your Wegovy journey.
Unlike generic online services, EverydayMeds provides ongoing conversion support with direct prescriber access throughout your transition. Our GPhC-registered pharmacy (#9012878) ensures genuine medication supply with proper cold-chain handling. The combination of clinical expertise, medication authenticity, and conversion specialisation makes EverydayMeds the preferred choice for patients requiring detailed Mounjaro to Wegovy dose conversion support across the UK.
Start Your Conversion Journey Today With Expert Support
Begin your Mounjaro to Wegovy dose conversion with confidence through EverydayMeds' comprehensive clinical service. New patients use code FIRST40 at checkout, whilst returning customers apply DOSE25 for additional savings on their conversion treatment. Our prescribers provide detailed conversion timing, potential side effect management, and ongoing monitoring throughout your transition. Every Wegovy order includes genuine Novo Nordisk medication, detailed administration guidance, and direct clinical support access. Visit https://everydaymeds.co.uk/collections/wegovy to complete your clinical assessment and receive personalised Mounjaro to Wegovy dose conversion recommendations from our expert team today.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
